This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Amneal Pharmaceuticals LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Heta Nishil Pandya: Innovator in Pain Treatment Compounds
Introduction
Heta Nishil Pandya is a prominent inventor based in Ahmedabad, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are useful for treating pain. Her innovative work has the potential to improve the quality of life for many individuals suffering from various types of pain.
Latest Patents
Heta holds a patent for her invention titled "Compounds useful to treat pain." This patent relates to compounds that act as bradykinin receptor antagonists. The pharmaceutical composition she developed comprises these compounds and is aimed at therapeutic use. The invention specifically addresses the treatment of urinary bladder pain and provides symptomatic relief from pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa due to infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. Heta has 1 patent to her name.
Career Highlights
Heta has established herself as a key figure in the pharmaceutical industry through her innovative research and development efforts. Her work at Amneal Pharmaceuticals LLC has allowed her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Vishal Bharatbhai Unadkat and Sandip Pareshbhai Mehta. Their collective expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Heta Nishil Pandya's contributions to the field of pain treatment through her innovative compounds highlight her role as a significant inventor in the pharmaceutical industry. Her work not only showcases her dedication to improving healthcare but also emphasizes the importance of innovation in addressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
